title: Clarification of entry criteria for the European Organization for Research and Treatment of Cancer H5-favorable trial of early-stage Hodgkin's disease.
authors.forename: G M
authors.initials: GM
authors.lastname: Rasp
authors.forename: M G
authors.initials: MG
authors.lastname: Haddock
authors.forename: J A
authors.initials: JA
authors.lastname: Martenson
mesh_terms: D006689:Hodgkin Disease / Q000473:pathology* / Q000532:radiotherapy; D006801:Humans; D008479:Mediastinal Neoplasms / Q000473:pathology*; D009367:Neoplasm Staging; D011379:Prognosis; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic